[go: up one dir, main page]

MX2014003865A - Sistema de desecho de parche transdermico. - Google Patents

Sistema de desecho de parche transdermico.

Info

Publication number
MX2014003865A
MX2014003865A MX2014003865A MX2014003865A MX2014003865A MX 2014003865 A MX2014003865 A MX 2014003865A MX 2014003865 A MX2014003865 A MX 2014003865A MX 2014003865 A MX2014003865 A MX 2014003865A MX 2014003865 A MX2014003865 A MX 2014003865A
Authority
MX
Mexico
Prior art keywords
devices
transdermal patch
waste system
activated carbon
pharmaceutical composition
Prior art date
Application number
MX2014003865A
Other languages
English (en)
Other versions
MX352051B (es
Inventor
William Fowler
Carter Anderson
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of MX2014003865A publication Critical patent/MX2014003865A/es
Publication of MX352051B publication Critical patent/MX352051B/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/80—Destroying solid waste or transforming solid waste into something useful or harmless involving an extraction step
    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/30—Destroying solid waste or transforming solid waste into something useful or harmless involving mechanical treatment
    • B09B3/35—Shredding, crushing or cutting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/14—Layer or component removable to expose adhesive
    • Y10T428/1476—Release layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24752—Laterally noncoextensive components
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24752—Laterally noncoextensive components
    • Y10T428/2476—Fabric, cloth or textile component
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/28—Web or sheet containing structurally defined element or component and having an adhesive outermost layer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/28—Web or sheet containing structurally defined element or component and having an adhesive outermost layer
    • Y10T428/2848—Three or more layers

Landscapes

  • Engineering & Computer Science (AREA)
  • Environmental & Geological Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Solid Wastes (AREA)

Abstract

Se proveen dispositivos para usarse en el desecho de las composiciones farmacéuticas; los aspectos de los dispositivos incluyen: un soporte que tiene una superficie; una capa de carbón activado presente sobre la superficie; y un adhesivo para asociar establemente una composición farmacéutica con la capa de carbón activado tras la aplicación de la composición farmacéutica a la capa de carbón activado; también se proveen métodos de uso de los dispositivos y kits que contienen los dispositivos.
MX2014003865A 2011-09-30 2012-09-27 Sistema de desecho de parche transdermico. MX352051B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161542050P 2011-09-30 2011-09-30
PCT/US2012/057607 WO2013049380A1 (en) 2011-09-30 2012-09-27 Transdermal patch disposal system

Publications (2)

Publication Number Publication Date
MX2014003865A true MX2014003865A (es) 2014-04-30
MX352051B MX352051B (es) 2017-11-06

Family

ID=47993218

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010724A MX386229B (es) 2011-09-30 2012-09-27 Sistema de desecho de parche transdérmico.
MX2014003865A MX352051B (es) 2011-09-30 2012-09-27 Sistema de desecho de parche transdermico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017010724A MX386229B (es) 2011-09-30 2012-09-27 Sistema de desecho de parche transdérmico.

Country Status (11)

Country Link
US (2) US8790583B2 (es)
EP (1) EP2760438B1 (es)
JP (1) JP5964435B2 (es)
KR (1) KR20140068058A (es)
CN (1) CN103764129A (es)
BR (1) BR112014005534A2 (es)
CA (1) CA2846956C (es)
MX (2) MX386229B (es)
RU (1) RU2014110700A (es)
TW (1) TW201328728A (es)
WO (1) WO2013049380A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
US10898934B2 (en) 2017-01-30 2021-01-26 Kirti H. Valia Drug disposal devices and methods of use
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
US11344933B2 (en) 2018-06-13 2022-05-31 Star Liberty LLC Kits for disposing of liquid pharmaceuticals and dissolved solid pharmaceuticals

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO814247L (no) * 1981-12-11 1983-06-13 Hansen Helly As Vernedrakt.
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4909256A (en) 1985-02-11 1990-03-20 The United States Of America, As Represented By The Secretary Of The Army Transdermal vapor collection method and apparatus
US5899856A (en) * 1988-09-08 1999-05-04 Sudormed, Inc. Dermal patch detecting long-term alcohol consumption and method of use
US5465713A (en) 1988-09-08 1995-11-14 Sudor Partners Energy-assisted transdermal collection patch for accelerated analyte collection and method of use
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5451444A (en) 1993-01-29 1995-09-19 Deliso; Evelyn M. Carbon-coated inorganic substrates
DE69429337T3 (de) 1993-04-02 2012-08-30 Anticancer Inc. Verfahren zur verabreichung von förderlichen zusammensetzungen auf die haarfollikel
US5396901A (en) 1994-01-11 1995-03-14 Phillips; Michael Transdermal dosimeter device
US6279736B1 (en) 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
US5804215A (en) 1997-03-21 1998-09-08 L. Perrigo Company Transdermal patch disposal system and method
US7011843B2 (en) 1997-10-01 2006-03-14 Lts Lohmann-Therapie Systeme Ag Method for protecting a human being against health impairment by ingestion of a transdermal therapeutic system
JP2001000774A (ja) 1999-06-21 2001-01-09 Hinomaru Carbo Techno Kk 洗濯機用浄化装置
US6660901B2 (en) 1999-09-24 2003-12-09 Glenda Church Charcoal skin patch
US6261595B1 (en) 2000-02-29 2001-07-17 Zars, Inc. Transdermal drug patch with attached pocket for controlled heating device
US6475513B1 (en) 2001-04-09 2002-11-05 Kiyoshi Yamada Skin-care pouch
PT1424973E (pt) * 2001-04-23 2010-06-02 Euro Celtique Sa Sistema de eliminação para uma forma de dosagem transdérmica
EP2062573B1 (en) 2001-05-01 2011-11-16 Euro-Celtique S.A. Abuse resistant opioid containing transdermal systems
US20030078552A1 (en) 2001-06-01 2003-04-24 The Procter & Gamble Company Odor-controlling disposal container
US7332182B2 (en) 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US20060110080A1 (en) 2002-02-27 2006-05-25 Thomas Toby R Packages and structures with selective dosing of active agent
ATE501712T1 (de) 2002-04-23 2011-04-15 Durect Corp Transdermale analgetische systeme mit reduziertem missbrauchspotential
EP1513532B1 (en) 2002-06-10 2007-02-28 Euro-Celtique S.A. Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
ATE423560T1 (de) 2002-08-20 2009-03-15 Euro Celtique Sa Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US7361184B2 (en) * 2003-09-08 2008-04-22 Joshi Ashok V Device and method for wound therapy
US7275645B2 (en) 2003-09-19 2007-10-02 Vesta Medical, Llc Handheld medical waste sorting device
US8535711B2 (en) 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
US20050211099A1 (en) * 2004-03-23 2005-09-29 Doughty David T Spiral composite adsorbent material
US7704598B2 (en) 2004-05-26 2010-04-27 Gore Enterprise Holdings, Inc. Durable covering for chemical protection
GB2432529B (en) 2005-11-25 2008-04-23 Univ Feng Chia Antimicrobial compositions and wound dressings
EP2178486A2 (en) 2007-08-09 2010-04-28 Ranbaxy Laboratories Limited Packaging kit for statins and compositions thereof
US7918776B2 (en) 2007-11-19 2011-04-05 Sherry Day Composition for disposing of unused medicines

Also Published As

Publication number Publication date
MX352051B (es) 2017-11-06
WO2013049380A1 (en) 2013-04-04
US20140296608A1 (en) 2014-10-02
EP2760438B1 (en) 2020-01-15
JP5964435B2 (ja) 2016-08-03
EP2760438A1 (en) 2014-08-06
KR20140068058A (ko) 2014-06-05
JP2014528828A (ja) 2014-10-30
CA2846956A1 (en) 2013-04-04
US20130085312A1 (en) 2013-04-04
TW201328728A (zh) 2013-07-16
MX386229B (es) 2025-03-18
US8790583B2 (en) 2014-07-29
BR112014005534A2 (pt) 2017-06-13
EP2760438A4 (en) 2015-07-15
CA2846956C (en) 2017-12-12
US9339856B2 (en) 2016-05-17
CN103764129A (zh) 2014-04-30
RU2014110700A (ru) 2015-11-10

Similar Documents

Publication Publication Date Title
MX2014003869A (es) Sistema de desecho de medicamento general.
CL2016001166A1 (es) Silicato de zirconio microporoso para el tratamiento de la hipercalemia
CL2013000396A1 (es) Composicion que comprende bacillus subtilis y bacillus licheniformis; proceso para elaborar dicha composicion; uso de dicha composición para el control de los fitonematodos y/o en la introduccion de una resistencia especifica a ellos.
CR20140321A (es) Sistema de administracion transdermica que contiene buprenofina
CR20160015A (es) Compuestos de éster boronato y composiciones farmacéuticas de los mismos
CL2013003518A1 (es) Estructura absorbente para articulos absorbentes que comprende un lienzo de soporte y una capa absorbente de material absorbente, en donde la capa absorbente incluye por lo menos un material polimerico superabsorbente y opcionalmente un material celulosico, en que la capa absorbente se soporta e inmoviliza en el lienzo de soporte; y un nucleo absorbente.
CL2014001149A1 (es) Una composicion adhesiva que comprende un material base y un plastificante; producto para uso sobre sustrato que contiene asfalto; y metodo para aplicar dicha composicion adhesivas.
CL2008002538A1 (es) Compuestos derivados de indol sustituidos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion viral
CR20110216A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
CL2014002096A1 (es) Compuestos heterocíclicos que comprenden un sistema enediino; conjugados de los mismos; composiciones que los comprenden; y uso para tratar el cáncer
UY35259A (es) Inhibidores macrocíclicos de serina proteasas de hepatitis c
MX2015013154A (es) Uso de higado desceluralizado por perfusion para receluralizacion de celulas de islote.
PE20151147A1 (es) Sistema de liberacion transdermica
MX2016002433A (es) Estructura de sustrato y metodo para su preparacion.
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
ES2570958T3 (es) Composición para el tratamiento de la fístula
CL2008001835A1 (es) Uso de compuestos derivados de guaninas policiclicas para tratar la inflamacion; compuestos derivados de guanina; y compocicion farmaceutica que los comprende.
NI201400042A (es) 2 - tiopirimidinonas
CL2008002041A1 (es) Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad.
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
CL2013001129A1 (es) Composicion que comprende una celula madre gbm6-ad de glioblastoma purificada; metodo de generacion de anticuerpos especificos para gbm6-ad; dicho anticuerpo; metodo para producir una vacuna de celulas dendriticas; y su uso para el tratamiento de cancer.
AR089256A1 (es) Sistemas portadores para recubrir paneles
CL2013002531A1 (es) Metodo para reducir un enlace c-o al enlace c-h por un sustrato utilizando un donante de hidrogeno, un catalizador de metal y una base en una mezcla de disolventes que comprende al menos dos disolventes en donde uno es agua.
ES2530578T3 (es) Cristales y cristales reticulados de Proteína A y métodos de uso de los mismos

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: VERDE ENVIRONMENTAL TECHNOLOGIES, INC.

FG Grant or registration